Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice nursing companies, today announced that it will host a conference call and web cast with the investment community on Tuesday, October 27, 2009 at 10:00 a.m. ET to discuss its financial and business performance. The Company intends to release its financial results for the quarter ended September 30, 2009 pre-market on Tuesday, October 27, 2009.
To participate in the conference call, please dial 877-208-2391 (Toll free) or 913-312-0667 (Toll) a few minutes before 10:00 a.m. ET on Tuesday, October 27, 2009. A replay of the conference call will be available through November 3, 2009. The replay dial in number is 888-203-1112 (Toll free) or 719-457-0820 (Toll). The replay pin number is 2824502.
The call will also be available on the Internet live and in our archived section thereafter on our Investor Relations page at the following web address: http://www.amedisys.com/investors
Amedisys, Inc. (the “Company”) is headquartered in Baton Rouge, Louisiana. Our common stock trades on the NASDAQ Global Select Market under the symbol “AMED”.
Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the “Investor Relations” subpage of our website, which is accessible by clicking on the tab labeled “Investors” on our website home page.We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission (“SEC”) disclosing the same information.In addition, we make available on the Investor Relations subpage of our website (under the link “SEC filings”) free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link “Corporate Governance”).
Contacts:
Amedisys, Inc.
Kevin LeBlanc, 225-292-2031
Director of
Investor Relations
kleblanc@amedisys.com
